#Anticholinesterases

Anticholinesterases antagonise AChE, decreasing the breakdown of ACh and therefore increasing its availability at the:
* Nicotinic receptor  
Increases muscle strength.
    * Reversal of non-depolarising neuromuscular blockade
* Muscarinic receptor  
Increases parasympathetic tone.

Acetylcholinesterases can be:
* Reversible
* Form a carbamylated enzyme complex
* Irreversible
    
|Property|Neostigmine|Organophosphates
|--|--|
|**Class**|Quaternary amine, forms carbamylated enzyme complex|Irreversible anticholinesterase
|**Uses**|Reversal of ND NMB, myasthenia gravis, analgesia|Insecticides, pesticides, chemical weapons
|**Presentation**|Clear, colourless, light stable solution at 2.5mg.ml<sup>-1</sup>||
|**Route of Administration**|PO, IV, intrathecal|Topical
|**Dosing**|0.05mg.kg<sup>-1</sup> for reversal, 15-30mg PO for MG||
|**Absorption**|Low PO bioavailability|Rapid topical absorption due to high lipid solubility
|**Distribution**|Does not cross BBB, V<sub>D</sub> 0.7L.kg<sup>-1</sup>|Crosses BBB
|**Metabolism**|Majority by plasma esterases to quaternary alcohol, with some hepatic metabolism|Not metabolised
|**Elimination**|55% unchanged in urine|t<sub>1/2</sub>α of weeks
|**Duration**|50 minutes|Until new AChE is synthesised
|**Resp**|Bronchospasm, ↑ secretion|Bronchospasm, ↑ secretion
|**CVS**|↓ HR (may be profound), ↓ CO|↓ HR, ↓ CO
|**CNS**| N/V and analgesic when administered intrathecally|Central cholinergic syndrome
|**MSK**| Reversal of NMB, ↑ fasciculations, ↑ sweating, may cause paralysis|Paralysis
|**GIT**|↑ Peristalsis, ↑ LoS tone, N/V|↑ Peristalsis, ↑ LoS tone, N/V
|**Other**|Muscarinic receptors affected at low dose, nicotinic receptors at high dose|May be reversed in initial stages (before organophosphate-AChE complex has 'aged') with pralidoxime

---

##References
1. Peck TE, Hill SA. Pharmacology for Anaesthesia and Intensive Care. 4th Ed. Cambridge University Press. 2014.  
2. ANZCA 2007 Feb/April
3. Petkov V. Essential Pharmacology For The ANZCA Primary Examination. Vesselin Petkov. 2012.
